INMD News and Press, InMode Ltd. From 01/13/22

The consumer healthcare market is a multi-trillion dollar industry worldwide that could double by 2028, according to Verified Market Research, which means there are opportunities to be had for patient investors. Companies delivering innovative products and services that improve patient trea...

InMode Expects Record Fourth Quarter & Full Year 2021 Financial Results, Q4 Revenue Between $109.5M-$110M InMode Expects Record Fourth Quarter & Full Year 2021 Financial Results, Q4 Revenue Between $109.5M-$110M Conference call to be held on February 10 at 8:30 a.m. ...

Shares of medical company InMode (NASDAQ: INMD) were up 197.3% in 2021, according to data provided by S&P Global Market Intelligence . This company went public in 2019, and its initial public offering (IPO) was priced at just $14 per share. In its still-short public his...

Let's talk about what we know about cosmetic surgery. First, it's costly. It's invasive, leaves scars, and has long recovery times. Cosmetic surgery is mostly for the rich and famous -- not regular folks, right? Well, InMode (NASDAQ: INMD) has a patented platform that changes the ga...

InMode to Present at the 24th Needham Virtual Growth Conference PR Newswire YOKNEAM, Israel , Jan. 3, 2022 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced that Moshe Mizrahy , ...

It's not often that a company can have its initial public offering IPO and just two years later be valued at 10 times its original size. But that's just what happened with medical device maker InMode (NASDAQ: INMD) . The company's laser-based technology allows for plastic surger...

The Premium Portfolio has gained +6.80% YTD compared to the S&P 500 +21.62% YTD and the Aurum Hedge Fund Industry Index +6.31% with one week to go. The Premium Portfolio compound annual growth rate (CAGR) of +25.57% compares favorably to the S&P 500 of +14.31% CAGR from 2018. ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Heads up, Jim Cramer fans. Today, the Mad Money  host announced a new position in Bausch Health (NYSE: BHC ) to capitalize on the uncertainty that the omicron variant may bring. Cramer likened BHC stock as a d...

InMode has new product soft launches not yet adding to revenue. Growth acceleration in the current quarter discussed. Base case fair value explained. For further details see: Why InMode Looks Good After Falling From $100

InMode shares have traded down over 20% in the last month. Using a DCF into 2025 we can see what sort of growth the market is pricing in after rallying several hundred percent over the last 18 months. Considering InMode has no debt and is growing in the high double digits with str...